Unconfigured Ad

Collapse

Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc

Forums Topics Posts Last Post
No forums found.
  •  
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by laura, 05-09-2011, 04:42 AM
35 responses
107,619 views
0 reactions
Last Post laura
by laura
 
Started by sci_guy, 01-23-2008, 11:19 PM
236 responses
684,191 views
1 reaction
Last Post ECO
by ECO
 
Started by CPG, 06-02-2014, 02:43 AM
3 responses
1,932 views
0 reactions
Last Post chrchang  
Started by kazi1, 05-28-2014, 02:10 PM
9 responses
8,565 views
0 reactions
Last Post mikep
by mikep
 
Started by BFM, 06-02-2014, 10:38 PM
0 responses
1,467 views
0 reactions
Last Post BFM
by BFM
 
Started by prs321, 06-02-2014, 09:30 AM
1 response
2,819 views
0 reactions
Last Post mikep
by mikep
 
Started by OstanNick, 06-02-2014, 09:56 AM
0 responses
1,207 views
0 reactions
Last Post OstanNick  
Started by Desai, 05-29-2014, 08:15 PM
12 responses
3,186 views
0 reactions
Last Post westerman  
Started by Inma, 06-02-2014, 08:47 AM
0 responses
2,143 views
0 reactions
Last Post Inma
by Inma
 
Started by Coryza, 06-01-2014, 01:17 AM
8 responses
5,936 views
0 reactions
Last Post blancha
by blancha
 
Started by Navy1991, 06-02-2014, 02:20 AM
3 responses
1,861 views
0 reactions
Last Post Navy1991  
Started by Parashar, 06-01-2014, 11:01 PM
1 response
1,449 views
0 reactions
Last Post Nikvailo  
No topics found.
  • Time
Clear All
Posted Photos 1 Photo
  • Time
Clear All

Webinars

Collapse

Recent Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    Today, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 02:55 AM
0 responses
7 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Working...